Science
NASA’s Artemis II mission soared to an unprecedented 149 million views, breaking the agency’s streaming record. According to NASA figures, the astronauts connected with hundreds of millions worldwide, demonstrating the continued public fascination with lunar exploration.
A record-breaking IPO from SpaceX has not only electrified the market but also revealed new directions for investors. As 2026’s IPO boom continues, major deals are no longer restricted to AI—other sectors now offer compelling opportunities.
SpaceX’s Falcon 9 rocket aims for its record-breaking 36th flight early on July 9, promising another major milestone in commercial spaceflight. Readers can tune in to watch this highly anticipated launch live, further reflecting SpaceX’s continuing leadership in space exploration.
A revolutionary shift in business networking is taking shape. SuperBroadband merges the largest 5G network with Starlink technology to deliver ultimate redundancy, unmatched coverage, and unprecedented simplicity for companies in search of dependable connectivity.
Wedbush has taken a bullish stance on SpaceX by initiating coverage with an Outperform rating and a $190 price target. Multiple outlets, including Investor’s Business Daily, Yahoo Finance, and Barron’s, highlight Dan Ives’s optimism toward Starlink and potential AI-driven growth.
More From Technology
Neko Health has introduced new innovations in its Health Scan experience, featuring body composition tracking and deeper integration with wearable devices. These advancements underscore the company’s commitment to continuous innovation and its global vision for proactive healthcare.
Although Anthropic has captured attention in the AI world, it remains unavailable to public investors. Here’s a glimpse into four AI stocks that might fill the gap for those seeking to stake a claim in the fast-evolving artificial intelligence market.
A recent discovery by Tenet Security’s Threat Labs reveals how one public Sentry key may compromise three of the most prominent AI coding platforms—Claude Code, Cursor, and Codex. This highlights the potential risk that even a seemingly minor oversight could jeopardize advanced AI technologies.
A remarkable Deal Days promotion is offering Windows 11 Pro for just $9.97, down from its usual $199 price. The sale, running through June 28, grants lifetime access to advanced features like BitLocker, Hyper-V, and Azure AD support, making it an attractive offer for both professionals and everyday users.
Green Bay has officially launched the Drone as First Responder program, a pioneering initiative by the city’s police and fire departments. The program aims to put eyes on the scene faster, thus enhancing situational awareness and response efficiency across all emergency calls.
SpaceX’s unprecedented initial public offering, which raised $75, has ignited debates on how technology-driven enterprises shape our global marketplace. Kirk Greene’s commentary highlights the triumph and uncertainty surrounding the world’s largest IPO to date.
SpaceX has highlighted a massive $22.7 trillion enterprise AI market, prompting fresh investor interest. Industry watchers note that two AI stocks in particular may dominate the sector, provided investors view this opportunity without succumbing to hype.
Astronomers using the James Webb Space Telescope have uncovered a salty twist in the atmosphere of the so-called Pink Planet, widely recognized as one of the coldest exoplanets ever found. This surprising development underscores the telescope’s power to reshape our understanding of distant worlds.
A new Phase 2 clinical trial is shining a spotlight on the potential benefits of Zabopegdutide for MASH patients. HistoIndex’s AI-powered analysis has revealed robust improvements in liver fibrosis, offering a promising glimpse of future treatment possibilities.
Savara Inc. (Nasdaq: SVRA) is restructuring its executive leadership following the resignation of Chief Financial and Administrative Officer Dave Lowrance for health-related reasons. The move comes as the company anticipates a key drug milestone that could significantly impact its future.
